Medicine and Dentistry
Gynecological Oncology
100%
Pelvis
86%
Ovarian Cancer
75%
Radical Hysterectomy
75%
Female Genital Tract Cancer
73%
Bloodless Surgery
72%
Laparoscopy
67%
Pelvis Lymphadenectomy
65%
Cervix
60%
Leiomyosarcoma
60%
Adenocarcinoma
60%
Endometrial Cancer
60%
Malignant Neoplasm
49%
Cervical Cancer
43%
Surgery
43%
Oncologist
37%
Bleeding
36%
Adnexal Mass
35%
Neoplasm
35%
Cytoreductive Surgery
35%
Disease
34%
Recurrent Disease
33%
Port Site Metastasis
32%
Tetrasomy
30%
Sentinel Lymph Node
30%
Precancerous Condition
30%
Posttransplant Lymphoproliferative Disease
30%
Abdominal Hysterectomy
30%
Mosaicism
30%
Lymph Node Metastasis
30%
Mesentery
30%
Fluorescence in Situ Hybridization
30%
Blood Salvage
30%
Large Intestine
30%
Renal Artery Thrombosis
30%
Cardiac Tamponade
30%
Amnion Fluid Embolism
30%
Ventricular Assist Device
30%
Liquid Biopsy
30%
Prenatal Diagnosis
30%
Pericardial Fluid
30%
Gestagen
30%
Transforming Growth Factor
30%
Programmed Cell Death
30%
Disease Process
22%
Cancer
21%
Operation Duration
20%
Salpingooophorectomy
20%
Adjuvant Therapy
20%
Chromosome Analysis
20%
Keyphrases
Gynecologic Oncology
99%
Bloodless Surgery
73%
Ovarian Cancer
71%
Gynecological Cancer
70%
Pelvic Lymphadenectomy
64%
Endometrial Cancer
60%
Laparoscopic Hysterectomy
60%
Jehovah's Witness Patients
48%
Cervical Cancer
44%
Oncology Service
42%
Adnexal Mass
40%
Laparoscopy
37%
Cell Salvage
36%
Port-site Metastasis
35%
Young Female
33%
Ultrastaging
30%
Right Ventricular Assist Device
30%
Intraoperative Frozen Section
30%
Patient Diagnosis
30%
Harmonic Shear
30%
FIGO Stage
30%
Tetrasomy
30%
Cancer Liquid Biopsy
30%
Stage IA1
30%
Leiomyosarcoma
30%
Older Patients
30%
Malignant Pericardial Effusion
30%
Mesentery
30%
Endometrial Precancer
30%
Vaginal Adenocarcinoma
30%
Suction Devices
30%
Complete Surgical Resection
30%
Hyphal Growth
30%
Cervical Carcinoma
30%
Patient Management
30%
Uterine Leiomyosarcoma
30%
Successful Placement
30%
Large Intestine
30%
Pelvic Lymph Node Metastasis
30%
Amniotic Fluid Embolism
30%
46,XY
30%
Fluorescence in Situ Hybridization
30%
Prenatal Diagnosis
30%
Radical Abdominal Hysterectomy
30%
Sentinel Lymph Node
30%
Macaque
30%
Advanced Directives
30%
Conventional Laparoscopy
30%
Transforming Growth Factor-β
30%
Cervix
30%